Resources

It’s World Cancer Day. Did you know these stats?

This World Cancer Day, we encourage men to talk to their doctor, understand their risk and take control of their health.

Movember-funded study gives people with incurable prostate cancer more time

New research findings from a Movember-funded clinical trial called ENZA-p reveals a world-first combination treatment approach that has led to longer and better-quality lives for men living with incurable prostate cancer.

Movember-funded study gives people with incurable prostate cancer more time

New research findings from a Movember-funded clinical trial called ENZA-p reveals a world-first combination treatment approach that has led to longer and better-quality lives for men living with incurable prostate cancer.

LuPSMA shows promise as first-line treatment for prostate cancer

A Peter MacCallum Cancer Centre study, part-funded by Movember, has led to a break-through in the treatment of early-stage prostate cancer.

A conversation about health equity with Dr. Brian Rivers

We sat down with Atlanta’s Dr. Brian Rivers, Professor at Morehouse School of Medicine (MSM) in the Department of Community Health and Preventive Medicine, Director of MSM Cancer Health Equity Institute, and member of Movember’s Global Cancer Advisory Committee to discuss health equity and what it would take to truly close the cancer care gap.

Announcing the 2023 Movember-PCF Challenge Award winner

Movember is contributing $500,000 towards this annual award which is granted to teams at some of the world’s leading cancer research institutions to support pioneering research in the field of prostate cancer.

Movember funds AI research to speed up personalised medicines for prostate cancer

Movember funding has supported ground-breaking new research which harnesses the use of artificial intelligence to improve prostate cancer treatment.

Movember funds AI research to speed up personalised medicines for prostate cancer

Movember funding has supported ground-breaking new research which harnesses the use of artificial intelligence to improve prostate cancer treatment.